Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

SIPAR negatively regulates STAT3 signaling and inhibits progression of melanoma.

Ren F, Su F, Ning H, Wang Y, Geng Y, Feng Y, Wang Y, Zhang Y, Jin Z, Li Y, Jia B, Chang Z.

Cell Signal. 2013 Nov;25(11):2272-80. doi: 10.1016/j.cellsig.2013.07.023. Epub 2013 Jul 31.

PMID:
23917203
2.

Nuclear termination of STAT3 signaling through SIPAR (STAT3-Interacting Protein As a Repressor)-dependent recruitment of T cell tyrosine phosphatase TC-PTP.

Ren F, Geng Y, Minami T, Qiu Y, Feng Y, Liu C, Zhao J, Wang Y, Fan X, Wang Y, Li M, Li J, Chang Z.

FEBS Lett. 2015 Jul 8;589(15):1890-6. doi: 10.1016/j.febslet.2015.05.031. Epub 2015 May 27.

PMID:
26026268
3.

Stat3 inhibits WTX expression through up-regulation of microRNA-370 in Wilms tumor.

Cao X, Liu D, Yan X, Zhang Y, Yuan L, Zhang T, Fu M, Zhou Y, Wang J.

FEBS Lett. 2013 Mar 18;587(6):639-44. doi: 10.1016/j.febslet.2013.01.012. Epub 2013 Jan 17.

4.

Downregulation of Stat3 in melanoma: reprogramming the immune microenvironment as an anticancer therapeutic strategy.

Emeagi PU, Maenhout S, Dang N, Heirman C, Thielemans K, Breckpot K.

Gene Ther. 2013 Nov;20(11):1085-92. doi: 10.1038/gt.2013.35. Epub 2013 Jun 27.

PMID:
23804077
5.

Signal transducer and activator of transcription 3 upregulates interleukin-8 expression at the level of transcription in human melanoma cells.

Oka M, Sakaguchi M, Okada T, Nagai H, Ozaki M, Yoshioka T, Inoue H, Mukaida N, Kikkawa U, Nishigori C.

Exp Dermatol. 2010 Aug;19(8):e50-5. doi: 10.1111/j.1600-0625.2009.00972.x.

6.

Protein tyrosine phosphatase Meg2 dephosphorylates signal transducer and activator of transcription 3 and suppresses tumor growth in breast cancer.

Su F, Ren F, Rong Y, Wang Y, Geng Y, Wang Y, Feng M, Ju Y, Li Y, Zhao ZJ, Meng K, Chang Z.

Breast Cancer Res. 2012 Mar 6;14(2):R38.

7.

The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation.

Yamamoto T, Sekine Y, Kashima K, Kubota A, Sato N, Aoki N, Matsuda T.

Biochem Biophys Res Commun. 2002 Oct 4;297(4):811-7.

PMID:
12359225
8.

Quercetin exerts anti-melanoma activities and inhibits STAT3 signaling.

Cao HH, Tse AK, Kwan HY, Yu H, Cheng CY, Su T, Fong WF, Yu ZL.

Biochem Pharmacol. 2014 Feb 1;87(3):424-34. doi: 10.1016/j.bcp.2013.11.008. Epub 2013 Nov 23.

PMID:
24275163
9.

ECHS1 interacts with STAT3 and negatively regulates STAT3 signaling.

Chang Y, Wang SX, Wang YB, Zhou J, Li WH, Wang N, Fang DF, Li HY, Li AL, Zhang XM, Zhang WN.

FEBS Lett. 2013 Mar 18;587(6):607-13. doi: 10.1016/j.febslet.2013.02.005. Epub 2013 Feb 14.

10.
11.

Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.

Zhang Y, Du XL, Wang CJ, Lin DC, Ruan X, Feng YB, Huo YQ, Peng H, Cui JL, Zhang TT, Wang YQ, Zhang H, Zhan QM, Wang MR.

Gastroenterology. 2012 Mar;142(3):521-530.e3. doi: 10.1053/j.gastro.2011.11.023. Epub 2011 Nov 19.

PMID:
22108192
12.

Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.

Yang J, Cai X, Lu W, Hu C, Xu X, Yu Q, Cao P.

Cancer Lett. 2013 Jan 28;328(2):243-51. doi: 10.1016/j.canlet.2012.09.019. Epub 2012 Sep 29.

PMID:
23032719
13.

Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.

Buettner R, Huang M, Gritsko T, Karras J, Enkemann S, Mesa T, Nam S, Yu H, Jove R.

Mol Cancer Res. 2007 Aug;5(8):823-32.

14.

Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression.

Hsu KW, Hsieh RH, Huang KH, Fen-Yau Li A, Chi CW, Wang TY, Tseng MJ, Wu KJ, Yeh TS.

Carcinogenesis. 2012 Aug;33(8):1459-67. doi: 10.1093/carcin/bgs165. Epub 2012 May 10.

15.

Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice.

Shanmugam MK, Rajendran P, Li F, Nema T, Vali S, Abbasi T, Kapoor S, Sharma A, Kumar AP, Ho PC, Hui KM, Sethi G.

J Mol Med (Berl). 2011 Jul;89(7):713-27. doi: 10.1007/s00109-011-0746-2. Epub 2011 Apr 5.

PMID:
21465181
16.

[Effects of STAT3 antisense oligodeoxynucleotides on apoptosis and proliferation of mouse melanoma cell line B16].

Tang GS, Cai JM, Ni J, Xiang YS, Cui JG, Zhu D, Dong JR.

Ai Zheng. 2006 Mar;25(3):269-74. Chinese.

PMID:
16536977
17.
18.

Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway.

Kamran MZ, Gude RP.

Biomed Pharmacother. 2013 Jun;67(5):399-405. doi: 10.1016/j.biopha.2013.03.020. Epub 2013 Apr 17.

PMID:
23639230
19.

Sorafenib inhibits endogenous and IL-6/S1P induced JAK2-STAT3 signaling in human neuroblastoma, associated with growth suppression and apoptosis.

Yang F, Jove V, Buettner R, Xin H, Wu J, Wang Y, Nam S, Xu Y, Ara T, DeClerck YA, Seeger R, Yu H, Jove R.

Cancer Biol Ther. 2012 May;13(7):534-41. doi: 10.4161/cbt.19603. Epub 2012 May 1.

PMID:
22406995
20.

STAT3 negatively regulates thyroid tumorigenesis.

Couto JP, Daly L, Almeida A, Knauf JA, Fagin JA, Sobrinho-Simões M, Lima J, Máximo V, Soares P, Lyden D, Bromberg JF.

Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):E2361-70. doi: 10.1073/pnas.1201232109. Epub 2012 Aug 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk